NCT00052455 2013-12-18
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
National Cancer Institute (NCI)
Phase 3 Completed
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Pfizer
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center